Evidence map›Paper›PMID 33291722›Full record

ReviewSensors (Basel, Switzerland)2020

Biosensors for the Detection of Bacterial and Viral Clinical Pathogens.

Luis Castillo-Henríquez, Mariana Brenes-Acuña, Arianna Castro-Rojas, Rolando Cordero-Salmerón, Mary Lopretti-Correa, José Roberto Vega-Baudrit

Open access · goldAbstract readReview
In one paragraph

Review in Sensors (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 176 citations in OpenAlex.

  1. Review
  2. Acoustofluidic Biosensors.Micromachines · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Luis Castillo-HenríquezNational Center for High Technology (CeNAT), National Laboratory of Nanotechnology (LANOTEC), San José 1174-1200, Costa Rica.ORCID 0000-0001-5276-4772
Mariana Brenes-AcuñaChemistry School, National University of Costa Rica, Heredia 86-3000, Costa Rica.
Arianna Castro-RojasChemistry School, National University of Costa Rica, Heredia 86-3000, Costa Rica.
Rolando Cordero-SalmerónChemistry School, National University of Costa Rica, Heredia 86-3000, Costa Rica.
Mary Lopretti-CorreaNuclear Research Center, Faculty of Science, Universidad de la República (UdelaR), Montevideo 11300, Uruguay.
José Roberto Vega-BaudritNational Center for High Technology (CeNAT), National Laboratory of Nanotechnology (LANOTEC), San José 1174-1200, Costa Rica.ORCID 0000-0002-2002-1744
Universidad Nacional · CRUniversidad de Costa Rica · CRUniversidad de la República de Uruguay · UY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biosensors are measurement devices that can sense several biomolecules, and are widely used for the detection of relevant clinical pathogens such as bacteria and viruses, showing outstanding results. Because of the latent existing risk of facing another pandemic like the one we are living through due to COVID-19, researchers are constantly looking forward to developing new technologies for diagnosis and treatment of infections caused by different bacteria and viruses. Regarding that, nanotechnology has improved biosensors' design and performance through the development of materials and nanoparticles that enhance their affinity, selectivity, and efficacy in detecting these pathogens, such as employing nanoparticles, graphene quantum dots, and electrospun nanofibers. Therefore, this work aims to present a comprehensive review that exposes how biosensors work in terms of bacterial and viral detection, and the nanotechnological features that are contributing to achieving a faster yet still efficient COVID-19 diagnosis at the point-of-care.

Indexed as

AnimalsBacteriaBiosensing TechniquesCOVID-19HumansNanotechnologyPandemicsSARS-CoV-2Virusesbacterial detectionbiosensorsclinical pathogenCOVID-19electrospun nanofibersnano-biosensorspoint-of-careSARS-CoV-2viral detection

Identifiers

PMID33291722
PMCPMC7730340
OpenAlexW3108110261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.